United States: Biogen Announces FDA Approval Of TOFIDENCE, A Tocilizumab Biosimilar Referencing ACTEMRA - Goodwin Procter LLP

Mondaq

06 Oct 2023 0 shares 1 views

Mondaq

Published 06 Oct 2023

On September 29, 2023, Biogen announced the FDA approval of TOFIDENCE (tocilizumab-bavi) intravenous formulation which is the first tocilizumab...

United States: Celltrion Announces FDA Approval Of ZYMFENTRA (Infliximab-dyyb) - Goodwin Procter LLP

On October 23, 2023, Celltrion announced FDA approval for ZYMFENTRA, a subcutaneous formulation for maintenance therapy for..

Mondaq 31 Oct 2023